Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Incretins and the specific mechanism of action of liraglutide, the first applicable human glucagon-like peptide 1 analog in the treatment of type 2 diabetes, Journal of Receptor Ligand and Channel Research, September 2010, Taylor & Francis, DOI: 10.2147/jrlcr.s6345.
You can read the full text:



The following have contributed to this page